Cargando…
PTEN inhibits BMI1 function independently of its phosphatase activity
BACKGROUND: PTEN is the second most mutated tumor suppressor gene other than p53. It suppresses tumorigenesis by dephosphorylating phosphatidylinositol (3,4,5)-triphosphate (PIP3) to phosphatidylinositol (4,5)-biphosphate (PIP2), thereby directly inhibiting phosphatidylinositol 3 kinase (PI3K)-media...
Autores principales: | Fan, Catherine, He, Lizhi, Kapoor, Anil, Rybak, Adrian P, De Melo, Jason, Cutz, Jean-Claude, Tang, Damu |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2777864/ https://www.ncbi.nlm.nih.gov/pubmed/19903340 http://dx.doi.org/10.1186/1476-4598-8-98 |
Ejemplares similares
-
Common reduction of the Raf kinase inhibitory protein in clear cell renal cell carcinoma
por: Hill, Brianne, et al.
Publicado: (2014) -
Biphasic Alteration of Butyrylcholinesterase (BChE) During Prostate Cancer Development
por: Gu, Yan, et al.
Publicado: (2018) -
BMI1, ATM and DDR
por: Lin, Xiaozeng, et al.
Publicado: (2015) -
Regulation of the Tumor Suppressor PTEN through Exosomes: A Diagnostic Potential for Prostate Cancer
por: Gabriel, Kathleen, et al.
Publicado: (2013) -
Amplification of MUC1 in prostate cancer metastasis and CRPC development
por: Wong, Nicholas, et al.
Publicado: (2016)